V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway A Hurtado-Lorenzo, M Skinner, JE Annan, M Futai, GH Sun-Wada, ... Nature cell biology 8 (2), 124-136, 2006 | 541 | 2006 |
The phospholipase D1 pathway modulates macroautophagy C Dall'Armi, A Hurtado-Lorenzo, H Tian, E Morel, A Nezu, RB Chan, ... Nature communications 1 (1), 142, 2010 | 185 | 2010 |
Challenges in IBD research: environmental triggers SM Ho, JD Lewis, EA Mayer, CN Bernstein, SE Plevy, E Chuang, ... Inflammatory bowel diseases 25 (Supplement_2), S13-S23, 2019 | 101 | 2019 |
Aldolase directly interacts with ARNO and modulates cell morphology and acidic vesicle distribution M Merkulova, A Hurtado-Lorenzo, H Hosokawa, Z Zhuang, D Brown, ... American Journal of Physiology-Cell Physiology 300 (6), C1442-C1455, 2011 | 97 | 2011 |
Challenges in IBD research: precision medicine LA Denson, M Curran, DPB McGovern, WA Koltun, RH Duerr, SC Kim, ... Inflammatory bowel diseases 25 (Supplement_2), S31-S39, 2019 | 87 | 2019 |
Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1 GC Luerman, C Nguyen, H Samaroo, P Loos, H Xi, A Hurtado‐Lorenzo, ... Journal of neurochemistry 128 (4), 561-576, 2014 | 79 | 2014 |
Immunoglobulin A targets a unique subset of the microbiota in inflammatory bowel disease JM Shapiro, MR de Zoete, NW Palm, Y Laenen, R Bright, M Mallette, K Bu, ... Cell host & microbe 29 (1), 83-93. e3, 2021 | 70 | 2021 |
Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6 … A Hurtado-Lorenzo, E Millan, V Gonzalez-Nicolini, D Suwelack, ... Molecular Therapy 10 (3), 507-524, 2004 | 58 | 2004 |
Challenges in IBD research: preclinical human IBD mechanisms TT Pizarro, TS Stappenbeck, F Rieder, MJ Rosen, JF Colombel, ... Inflammatory bowel diseases 25 (Supplement_2), S5-S12, 2019 | 54 | 2019 |
Neuronal expression of the transcription factor Gli1 using the Tα1 α-tubulin promoter is neuroprotective in an experimental model of Parkinson's disease D Suwelack, A Hurtado-Lorenzo, E Millan, V Gonzalez-Nicolini, ... Gene therapy 11 (24), 1742-1752, 2004 | 50 | 2004 |
Multiomics analyses to deliver the most effective treatment to every patient with inflammatory bowel disease RK Weersma, RJ Xavier, RK Weersma, JC Barrett, S Vermeire, RJ Xavier, ... Gastroenterology 155 (5), e1-e4, 2018 | 33 | 2018 |
Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States JD Lewis, LE Parlett, MLJ Funk, C Brensinger, V Pate, Q Wu, GK Dawwas, ... Gastroenterology 165 (5), 1197-1205. e2, 2023 | 32 | 2023 |
Challenges in IBD research: pragmatic clinical research FI Scott, DT Rubin, S Kugathasan, A Bousvaros, CO Elson, RD Newberry, ... Inflammatory bowel diseases 25 (Supplement_2), S40-S47, 2019 | 25 | 2019 |
Heat shock protein 90 modulates LRRK2 stability: potential implications for Parkinson's disease treatment A Hurtado-Lorenzo, VS Anand Journal of Neuroscience 28 (27), 6757-6759, 2008 | 25 | 2008 |
Gene therapy for Parkinson's disease: recent achievements and remaining challenges MG Castro, A David, A Hurtado-Lorenzo, D Suwelack, E Millan, T Verakis, ... Histology and histopathology 16 (4), 1225-1238, 2001 | 22 | 2001 |
Defining the path forward for biomarkers to address unmet needs in inflammatory bowel diseases G Honig, C Heller, A Hurtado-Lorenzo Inflammatory bowel diseases 26 (10), 1451-1462, 2020 | 17 | 2020 |
Challenges in IBD research: novel technologies M Dhyani, N Joshi, WA Bemelman, MS Gee, V Yajnik, A D’Hoore, ... Inflammatory bowel diseases 25 (Supplement_2), S24-S30, 2019 | 17 | 2019 |
Defective thyroglobulin storage in LDL receptor-associated protein-deficient mice S Lisi, R Botta, A Pinchera, AB Collins, S Refetoff, P Arvan, G Bu, ... American Journal of Physiology-Cell Physiology 290 (4), C1160-C1167, 2006 | 13 | 2006 |
Chronic abdominal pain in IBD research initiative: unraveling biological mechanisms and patient heterogeneity to personalize treatment and improve clinical outcomes A Hurtado-Lorenzo, G Honig, SA Weaver, PB Larkin, C Heller Crohn's & Colitis 360 3 (3), otab034, 2021 | 12 | 2021 |
Use of recombinant adenovirus for gene transfer into the rat brain: evaluation of gene transfer efficiency, toxicity, and inflammatory and immune reactions A Hurtado-Lorenzo, A David, C Thomas, MG Castro, PR Lowenstein Viral Vectors for Gene Therapy: Methods and Protocols, 113-133, 2003 | 12* | 2003 |